Consensus Of Systemic Lupus Erythematosus [consenso De Lúpus Eritematoso Sistêmico]

dc.creatorBorba E.F.
dc.creatorLatorre L.C.
dc.creatorBrenol J.C.T.
dc.creatorKayser C.
dc.creatorda Silva N.A.
dc.creatorZimmermann A.F.
dc.creatorde Padua P.M.
dc.creatorCostallat L.T.L.
dc.creatorBonfa E.
dc.creatorSato E.I.
dc.date2008
dc.date2015-06-30T19:31:29Z
dc.date2015-11-26T14:45:24Z
dc.date2015-06-30T19:31:29Z
dc.date2015-11-26T14:45:24Z
dc.date.accessioned2018-03-28T21:54:35Z
dc.date.available2018-03-28T21:54:35Z
dc.identifier
dc.identifierRevista Brasileira De Reumatologia. , v. 48, n. 4, p. 196 - 207, 2008.
dc.identifier4825004
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-58149131237&partnerID=40&md5=6b5515d941254873d114a2a60a64f6a3
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/106593
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/106593
dc.identifier2-s2.0-58149131237
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1252455
dc.description[No abstract available]
dc.description48
dc.description4
dc.description196
dc.description207
dc.descriptionBus, V., Maury, E.E., Hochberg, M.C., The epidemiology of systemic lupus crythematosus (2007) Dubois lupus crythematosus, pp. 34-44. , Wallace DJ, Hahn BH, editors, 7th ed. Philadelphia: Lippincott Williams & Wilkins;
dc.descriptionTan, E.M., Cohen, A.S., Fries, J.F., The 1982 revised criteria for the classification of systemic lupus erythematosus (1982) Arthritis Rheum, 25, pp. 1271-1277
dc.descriptionHochberg, M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (1997) Arthritis Rheum, 40, p. 1725
dc.descriptionDellavance, A., Gabriel, A., Cintra, A.F.U., II Consenso Brasileiro de Fator Antinuclear em Células HEP-2. Dcfinições para padronização da pesquisa contra constituintes do núcleo, nucléolo, citoplasma e aparelho mitótico e suas associações clínicas. (2003) Rev Bras Reumatol, 43, pp. 129-140
dc.descriptionWallace, D.J., Principles of therapy and local measures (2007) Dubois lupus erythematosus, pp. 1132-1144. , Wallace DJ, Hahn BH, editors, 7th ed. Philadelphia: Lippincott Williams & Wilkins;
dc.descriptionTench, C.M., McCarthy, J., McCurdie, I., Fatigue in systemic lupus erythematosus: A randomized controlled trial of exercise (2003) Rheumatology (Oxford), 42 (9), pp. 1050-1054
dc.descriptionKeyser, R.E., Rus, V., Cade, W.T., Kalappa, N., Flores, R.H., Handwerger, B.S., Evidence for aerobic insufficiency in women with systemic Lupus erythematosus (2003) Arthritis Rheum, 49 (1), pp. 16-22
dc.descriptionCarvalho, M.R., Sato, E.I., Tebexreni, A.S., Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus (2005) Arthritis Rheum, 53 (6), pp. 838-844
dc.descriptionAyán, C., Martín, V., Systemic Jupus erythematosus and exercise (2007) Lupus, 16 (1), pp. 5-9
dc.descriptionMeasurement of fatigue in systemic lupus erythematosus: A systematic review (2007) Arthritis Rheum, 57 (8), pp. 1348-1357. , Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue
dc.descriptionCarvalho, J.F., Blank, M., Kiss, E., Anti-vitamin D, vitamin D in SLE: Preliminary results (2007) Ann N Y Acad Sci, 1109, pp. 550-557
dc.descriptionKamen, D.L., Cooper, G.S., Bouali, H., Vitamin D deficiency in systemic lupus erythematosus (2006) Autoimmun Rev, 5 (2), pp. 114-117
dc.descriptionRahman, P., Gladman, D.D., Urowitz, M.B., Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus (1998) J Rheumatol, 25 (9), pp. 1716-1719
dc.descriptionJewell, M.L., McCauliffe, D.P., Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment (2000) J Am Acad Dermatol, 42 (6), pp. 983-987
dc.descriptionGhaussy, N.O., Sibbitt Jr, W., Bankhurst, A.D., Qualls, C.R., Cigarette smoking and disease activity in systemic lupus erythematosus (2003) J Rheumatol, 30 (6), pp. 1215-1221
dc.descriptionWesterweel, P.E., Luyten, R.K., Koomans, H.A., Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus Arthritis Rheum 20071, 56 (5), pp. 1384-1396
dc.descriptionMeinao, I.M., Sato, E.I., Andrade, L.E., Controlled trial with chloroquine diphosphate in systemic lupus erythematosus (1996) Lupus, 5, pp. 237-241
dc.descriptionA randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus (1991) N Engl J Med, 324, pp. 150-154. , The Canadian Hydroxychloroquine Study Group
dc.descriptionSachet, J.C., Borba, E.F., Bonfá, E., Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients (2007) Lupus, 16 (4), pp. 273-278
dc.descriptionBorba, E.F., Bonfa, E., Long term beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy (2001) J Rheumatol, 28, pp. 780-785
dc.descriptionWallace, D.J., Linker-Israeli, M., Metzger, A.L., Stecher, V.J., The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE (1993) Lupus, 2 (SUPPL. 1), pp. S13-S15
dc.descriptionKirou, K.A., Boumpas, D.T., Systemic glucocorticoid therapy in systemic lupus erythematosus (2007) Dubois lupus erythematosus, pp. 1175-1197. , Wallace DJ, Hahn BH, editors, 7th ed. Philadelphia: Lippincott Williams & Wilkins;
dc.descriptionBoumpas, D.T., Chrousos, G.P., Wilder, R.L., Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates (1993) Ann Intern Med, 119, pp. 1198-1208
dc.descriptionMaccune, W.J., Marder, W.E., Riskalla, M., Immunossuppressive drug therapy (2007) Dubois lupus erythematosus, pp. 1198-1224. , Wallace DJ, Hahn BH, editors, 7th ed. Philadelphia: Lippincott Williams & Wilkins;
dc.descriptionCarneiro, J.R., Sato, E.I., Double blind, randomized, placebo controlled clinical trial of methotrexatc in systemic lupus erythematosus (1999) J Rheumatol, 26, pp. 1275-1279
dc.descriptionWalchner, M., Messer, G., Kind, P., Phototesting and photoprotection in LE (1997) Lupus, 6, pp. 167-174
dc.descriptionVila, L.M., Mayor, A.M., Valentin, A.H., Association of sunlight exposure and photoprotection measures with clinical outcome. in systemic lupus erythematosus (1999) P R. Health Sci J, 18, pp. 89-94
dc.descriptionMaggio, K.L., Singer, M.T., James, W.D., Clinical pearl: Discoid lupus erythematosus - treatment with occlusive compression (1996) J Am Acad Dermatol, 35, pp. 627-628
dc.descriptionRangel, L.V., Santiago, J.M., Souza, J.C.C., Terapia tópica com pimecrolimus ern lesão cutânea refratária de lupus eritematoso sistêmica. (2006) Rev Bras Reumatol, 46, pp. 230-233
dc.descriptionLuger, T., Paul, C., Potential new indications of topical calcineurin inhibitors (2007) Dermatology, 215 (SUPPL. 1), p. 45
dc.descriptionCostner, M.I., Sontheimer, R.D., Provost, T.T., Lupus erythematosus (2003) Cutaneous manifestations of rheumatic diseases, pp. 15-64. , Sontheimer RD, Provost TT, editors, Philadelphia: Lippincott Williams & Wilkins;
dc.descriptionWenzel, J., Brähler, S., Bauer, R., Tüting, T., Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: Results of a retrospective study in 43 patients (2005) Br J Dermatol, 153, pp. 157-162
dc.descriptionCallen, J.P., Spencer, L.V., Burruss, J.B., Holtman, J., Azathioprine: An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis (1991) Arch Dermatol, 127, pp. 515-522
dc.descriptionDavis, J.C., Klippel, J.H., (2004) Antimalarials and immunossupressive therapies, pp. 1279-1281. , Systemic Lupus Erythematosus. 4th ed
dc.descriptionBezerra, E.L.M., Vilar, M.J.P., Trindade Neto, P.B., Sato, E.I., Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus (2005) Arthritis Rheum, 52, pp. 3073-3078
dc.descriptionHall, R.P., Lawley, T.J., Smith, H.R., Katz, S.I., Bullous eruption of systemic lupus erythematosus: Dramatic response to dapsone therapy (1982) Ann Intern Med, 97, pp. 165-170
dc.descriptionCotell, S., Robinson, N.D., Chan, L.S., Autoimmune blistering skin diseases (2000) Am J Emerg Med, 18, pp. 288-299
dc.descriptionAtra, E., Sato, E.I., Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide (1993) Clin Exp Rheumatol, 11, pp. 487-493
dc.descriptionCoelho, A., Souto, M.I., Cardoso, C.R., Long-term thalidomide use in refractory cutaneous lesions in systemic lupus erythematosus: A 65 series of Brazilian patients (2005) Lupus, 14, pp. 434-439
dc.descriptionPisoni, C.N., Obermoser, G., Cuadrado, M.J., Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: Poor results with mycophenolate mofetil (2005) Clin Exp Rheumatol, 23, pp. 393-396
dc.descriptionSchanz, S., Ulmer, A., Rassner, G., Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil (2002) Br J Dermatol, 147, pp. 174-178
dc.descriptionHorizon, A.A., Weisman, M.H., Nonsteroidals and salicylates for systemic lupus erythematosus (2007) Dubois lupus erythematosus, pp. 1145-1151. , Wallace DJ, Hahn BH, editors, 7th ed. Philadelphia: Lippincott Williams & Wilkins;
dc.descriptionWilliams, H.J., Egger, M.J., Singer, J.Z., Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus (1994) J Rheumatol, 21, pp. 1457-1462
dc.descriptionRahman, P., Humphrey-Murto, S., Gladman, D.D., Urowitz, M.B., Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis (1998) J Rheumatol, 25, pp. 243-246
dc.descriptionQuismorici Jr, F.P., Hematologic and lymphoid abnormalities in systemic lupus erythematosus (2007) Dubois lupus erythematosus, pp. 801-828. , Wallace DJ, Hahn BH, editors, Philadelphia: Lippincott Williams & Wilkins;
dc.descriptionGomard-Menesson, E., Ruivard, M., Koenig, M., Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases (2006) Lupus, 15, pp. 223-231
dc.descriptionJacob, H.S., Pulse steroids in hematologic diseases (1985) Hosp Pract (Off Ed), 20, pp. 87-94
dc.descriptionPirofsky, B., Immune haemolytic disease: The autoimmune haemolytic anaemias (1975) Clin Haematol, 4, pp. 167-180
dc.descriptionAviña-Zubieta, J.A., Galindo-Rodriguez, G., Robledo, I., Long-term effectiveness of danazol, corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus (2003) Lupus, 12, pp. 52-57
dc.descriptionAlba, P., Karim, M.Y., Hunt, B.J., Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome (2003) Lupus, 12, pp. 633-635
dc.descriptionWang, S.-W., Cheng, T.-T., Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin-A (2005) Lupus, 14, pp. 483-485
dc.descriptionPignon, J.M., Poirson, E., Rochant, H., Danazol in autoimmune haemolytic anaemia (1993) Br J Haematol, 83, pp. 343-345
dc.descriptionPerotta, S., Locatelli, F., La Manna, A., Anti-CD20 monoclonal antibody (rituximabe) for life-threatning autoimmune hemolytic anaemia in a patient with systemic lupus erythematosus (2002) Br J Haematol, 116, pp. 465-467
dc.descriptionMajer, R.V., Hyde, R.D., High-dose intravenous immunoglobulin in the treatment of autoimmune haemolytic anaemia (1988) Clin Lab Haematol, 10, pp. 391-395
dc.descriptionKondo, H., Date, Y., Sakai, Y., Effective simultaneous rhG-CSF and methylprednisolone pulse therapy in agranulocytosis associated with systemic lupus erythematosus (1994) Am J Hematol, 46, pp. 157-158
dc.descriptionEuler, H.H., Harten, P., Zeuner, R.A., Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections (1997) J Rheumatol, 24, pp. 215-237
dc.descriptionCervera, H., Jara, L.J., Pizarro, S., Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans syndrome (1995) J Rheumatol, 22, pp. 1867-1871
dc.descriptionRoach, B.A., Hutchinson, G.J., Treatment of refractory, systemic lupus erythematosusassociated thrombocytopenia with intermittent low-dose intravenous cyclophosphamide (1993) Arthritis Rheum, 36, pp. 682-684
dc.descriptionArnal, C., Piette, J.C., Leone, J., Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases (2002) J Rheumatol, 29, pp. 75-83
dc.descriptionGoebel, K.M., Gassel, W.D., Goebel, F.D., Evaluation of azathioprine in autoimmune thrombocytopenia and lupus erythematosus (1973) Scand J Haematol, 10, pp. 28-34
dc.descriptionVasoo, S., Thumboo, J., Fong, K.Y., Refractory immune thrombocytopenia in systemic lupus erythematosus: Response to mycophenolate mofetil (2003) Lupus, 12, pp. 630-632
dc.descriptionQuartucio, L., Sacco, S., Franzolini, N., Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus (2006) Lupus, 15, pp. 76-79
dc.descriptionShanafelt, T.D., Madueme, H.L., Wolf, R.C., Rituximab for immune cytopenia in adults: Idiopathic thrombocytopenic purpura,autoimmune hemolytic anemia,and Evans syndrome (2003) Mayo Clin Proc, 78, pp. 1340-1346
dc.descriptionTen Cate, R., Smiers, F.J., Bredius, R.G., Anti-CD20 monoclonal antibody(rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus (2004) Rheumatology (Oxford), 43, p. 244
dc.descriptionTer Borg, E.J., Kallenberg, C.G., Treatment of severe thrombocy-topenia in systemic lupus erythematosus with intravenous gammaglobulin (1992) Ann Rheum Dis, 51, pp. 1149-1151
dc.descriptionChandramouli, N.B., Rodgers, G.M., Prolonged immunoglobulin and platelet infusion for treatment of immune thrombocytopenia (2000) Am J Hematol, 65, pp. 85-86
dc.descriptionYou, N.Y., Tefferi, A., Nagorney, D.M., Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus (2004) Ann Surg, 240, pp. 286-296
dc.descriptionMaksimowicz-McKinnon, K., Manzi, S., Cardiovascular manifestations of lupus (2007) Dubois lupus erythematosus, pp. 663-677. , Wallace DJ, Hahn BH, editors, Philadelphia: Lippincott Williams & Wilkins;
dc.descriptionWesterweel, P.E., Luyten, R.K., Koomans, H.A., Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus (2007) Arthritis Rheum, 56 (5), pp. 1384-1396
dc.descriptionManzi, S., Meilahn, E.N., Rairie, J.E., Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study (1997) Am J Epidemiol, 145 (5), pp. 408-415
dc.descriptionPetri, M., Lakatta, C., Magder, L., Goldman, D., Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis (1994) Am J Med, 96, pp. 254-259
dc.descriptionPetri, M., Kiani, A.N., Post, W., Magder, L., Lupus Atherosclerosis Preventio Study (LAPS): A randomized double blind placebo controlled trial of atorvastatin versus placebo (2006) Arthritis Rheum, 54 (SUPPL.), p. 520. , S
dc.descriptionFerreira, G.A., Navarro, T.P., Telles, R.W., Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: An 8 weeks controlled trial (2007) Rheumatology (Oxford), 46 (10), pp. 1560-1565
dc.descriptionD'Cruz D, Khamashta MA, Hughes G: Pulmonary manifestations of systemic lupus erythematosus. In: Wallace DJ, Hahn BH. Dubois' Lupus Erythematosus. Philadelphia, 7th ed. Lippincott Williams & Wilkins
dc.description2007. p. 678-99Man, B.L., Mok, C.C., Serositis related to systemic lupus erythematosus: Prevalence and outcome (2005) Lupus, 14, pp. 822-826
dc.descriptionKao, A.H., Manzi, S., How to manage patients with cardiopulmonary disease? (2002) Best Pract Res Clin Rheumatol, 16, pp. 211-227
dc.descriptionMcKnight, K.M., Adair, N.E., Agudelo, C.A., Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus (1991) Arthritis Rheum, 34, pp. 1483-1484
dc.descriptionSchwab, E.P., Schumacher Jr, H.R., Freundlich, B., Callegari, P.E., Pulmonary alveolar hemorrhage in systemic lupus erythematosus (1993) Semin Arthritis Rheum, 23, pp. 8-15
dc.descriptionWeinrib, L., Sharma, O.P., Quismorio Jr, F.P., A long-term study of interstitial lung disease in systemic 1upus erythematosus (1990) Semin Arthritis Rheum, 20, pp. 48-56
dc.descriptionOkada, M., Suzuki, K., Matsumoto, M., Intermittent intravenous cyclophosphamide pulse therapy for the treatment of active interstitial lung disease associated with collagen vascular diseases (2007) Mod Rheumatol, 17, pp. 131-136
dc.descriptionHeresi, G.A., Minai, O.A., Lupus-associated pulmonary hypertension: Long-term response to vasoactive therapy (2007) Respir Med, 101, pp. 2099-2107
dc.descriptionDenton, C.P., Humbert, M., Rubin, L., Black, C.M., Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: A subgroup analysis of the pivotal clinical trials and their open-label extensions (2006) Ann Rheum Dis, 65, pp. 1336-1340
dc.descriptionGaliè, N., Manes, A., Farahani, K.V., Pulmonary arterial hypertension associated to connective tissue diseases (2005) Lupus, 14, pp. 713-717
dc.descriptionSanchez, O., Sitbon, O., Jaïs, X., Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension (2006) Chest, 130, pp. 182-189
dc.descriptionThe American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42: 599-608, 1999Boumpas, D.T., Yamada, H., Patronas, N.J., Pulse cyclophosphamide for severe neuropsychiatric lupus (1991) Q J Med, 81, pp. 975-984
dc.descriptionWest SG: The nervous system. In: Wallace DJ, Hahn BH. Dubois' Lupus Erythematosus. Philadelphia. 7th ed. Lippincott Williams & Wilkins
dc.description2007. p. 707-46Barile, L., Lavalle, C., Transverse myelitis in systemic lupus erythematosus - the effect of IV pulse methylprednisolone and cyclophosphamide (1992) J Rheumatol, 19, pp. 370-372
dc.descriptionTokunaga, M., Saiko, K., Kawabata, D., Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system (2007) Ann Rheum Dis, 66, pp. 470-475
dc.descriptionDooley MA: Clinical and laboratory features of lupus nephritis. In: Wallace DJ, Hahn BH. Dubois' Lupus Erythematosus. Philadelphia, 7th ed. Lippincott Williams & Wilkins
dc.description2007. p. 1112-30Grande, J.P., Ballow, J.E., Renal biopsy in lupus nephritis (1998) Lupus, 7, pp. 611-617
dc.descriptionWeening, J.J., D'Agati, V.D., Schwartz, M.M., The classification of glomerulonephritis in systemic lupus erythematosus revisited (2004) J Am Soc Nephrol, 15 (2), pp. 241-250
dc.descriptionWeening, J.J., D'Agati, V.D., Schwartz, M.M., The classification of glomerulonephritis in systemic lupus erythematosus revisited (2004) Kidney Int, 65 (2), pp. 521-530
dc.descriptionThe American College of Rheumatology response criteria for proliferative and membranous renal disease in SLE clinical trials (2006) Arthritis Rheum, 54, pp. 421-432. , Renal disease subcommitee of the ACRAd Hoc Committee on SLE response criteria
dc.descriptionRuggenenti, P., Perna, A., Gherardi, G., Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy (1998) Lancet, 352, pp. 1252-1256
dc.descriptionPraga, M., Slowing the progression of renal failure (2002) Kidney Int, (SUPPL. 80), pp. 18-22
dc.descriptionPollak, V.E., Treatment of lupus nephritis (1983) Nippon Jinzo Gakkai Shi, 25, pp. 776-785
dc.descriptionKimberly, R.P., Lockshin, M.D., Sherman, R.L., High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus (1981) Am J Med, 70, pp. 817-824
dc.descriptionAustin 3rd, H.A., Klippel, J.H., Balow, J.E., Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs (1986) N Engl J Med, 314, pp. 614-619
dc.descriptionBalow, J.E., Choosing treatment for proliferative lupus nephritis (2002) Arthritis Rheum, 46, pp. 1981-1983
dc.descriptionFlanc, R.S., Roberts, M.A., Strippoli, G.F., Treatment of diffuse proliferative lupus nephritis: A meta-analysis of randomized controlled trials (2004) Am J Kidney Dis, 43, pp. 197-208
dc.descriptionBansal, V.Y., Beto, J.A., Treatment of lupus nephritis: A meta-analysis of clinical trials (1997) Am J Kidney Dis, 29, pp. 193-199
dc.descriptionChan, T.M., Li, F.K., Tang, C.S., Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis (2000) Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med, 343, pp. 1156-1162
dc.descriptionHoussiau, F.A., Vasconcelos, C., D'Cruz, D., Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide (2002) Arthritis Rheum, 46, pp. 2121-2131
dc.descriptionContreras, G., Pardo, V., Leclercq, B., Sequential therapies for proliferative lupus nephritis (2004) N Engl J Med, 350, pp. 971-980
dc.descriptionGinzler, E.M., Aranow, C., Buyon, J., A multicenter study of MMF Vs IV cyclophosphamide as induction therapy for severe lupus nephritis: Preliminary results (2005) N Eng J Med, 353, pp. 2219-2228
dc.descriptionSinclair, A., Appel, G., Dooley, M.A., Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: Rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS) (2007) Lupus, 16 (12), pp. 972-980
dc.descriptionKolasinski, S.L., Chung, J.B., Albert, D.A., What do we know about lupus membranous nephropathy? An analytic review (2002) Arthritis Rheum, 47, pp. 450-455
dc.descriptionChan, T.M., Li, F.K., Hao, W.K., Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression (1999) Lupus, 8, pp. 545-551
dc.descriptionRadhakrishnan, J., Kunis, C.L., D'Agati, V., Appel, G.B., Cyclosporine treatment of lupus membranous nephropathy (1994) Clin Nephrol, 42, pp. 147-154
dc.descriptionMok, C.C., Ying, K.Y., Lau, C.S., Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: An open-label trial (2004) Am J Kidney Dis, 43, pp. 269-276
dc.descriptionBotha, E.F., Guedes, L.K., Christmann, R.B., Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria (2006) Rheumatol Int, 26 (12), pp. 1078-1083
dc.descriptionSabahi, R., Anolik, J.H., B-cell-target for SLE (2006) Drugs, 66 (15), pp. 1933-1948
dc.descriptionBhat, P., B lymphocytes and lupus nephritis: New insights into pathogenesis and targeted therapies (2008) Kidney Int, 73, pp. 261-268
dc.descriptionStone, J.H., End-stage renal disease in lupus: Disease activity, dialysis, and the outcome of transplantation (1998) Lupus, 7, pp. 654-659
dc.descriptionUrowitz, M.B., Gladman, D.D., Farewell, V.T., Lupus and pregnancy studies (1993) Arthritis Rheum, 36, pp. 1392-1397
dc.descriptionClowaw, M.E., Magder, L.S., Petri, M., The impact of increased lupus activity on obstetric outcomes (2005) Arthritis Rheum, 52, pp. 514-521
dc.descriptionSánchez-Guerrero, J., Uribe, A.G., Jiménez-Santana, L., A trial of contraceptive methods in women with Systemic lupus erythematosus (2005) N Engl J Med, 353, pp. 2539-2549
dc.descriptionPetri, M., Kim, M.Y., Kalunian, K.C., OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus (2005) N Engl J Med, 353, pp. 2550-2558
dc.descriptionBuyon, J.P., Kalunian, K.C., Ramsey-Goldman, R., Assessing disease activity in SLE patients during pregnancy (1999) Lupus, 8, pp. 677-684
dc.descriptionPetri, M., (2003) Pregnancy in SLE, pp. 1427-1430. , ed. Rheumatology. 3th. ED;
dc.descriptionWilson, W.A., Gharavi, A.E., Koike, T., International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop (1999) Arthritis Rheum, 42, pp. 1309-1311
dc.descriptionBuyon, J.P., Clancy, R.M., Neonatal lupus syndromes (2003) Curr Opin Rheumatol, 15, pp. 535-541
dc.descriptionCervera, R., Font, J., Carmona, F., Balasch, J., Pregnancy outcome in systemic lupus erythematosus: Good news for the new millennium (2002) Autoimmun Rev, 1, pp. 354-359
dc.descriptionAnderson, P.O., Drugs and breast feeding (1979) Semin Perinatol, 3, pp. 271-278
dc.descriptionBermas, B.L., Hill, J.A., Effects of immunosuppressive drugs during pregnancy (1995) Arthritis Rheum, 38, pp. 1722-1732
dc.descriptionLevy, R.A., Vilela, V.S., Cataldo, M.J., Hydroxychloroquine in lupus pregnancy: Double-blind and placebo-controled study (2001) Lupus, 10, pp. 401-404
dc.descriptionOst, L., Wettrell, G., Bjorkhem, I., Rane, A., Prednisolone excretion in human milk (1985) J Pediatr, 106, pp. 1008-1011
dc.descriptionPetri, M., Hydroxychloroquine use in Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis (1996) Lupus, 5 (SUPPL. 1), pp. S16-S22
dc.descriptionBertolaccini, M.L., Khamashta, M.A., Laboratory diagnosis and management challenges in the antiphospholipid syndrome (2006) Lupus, 15, pp. 172-178
dc.descriptionJungers, P., Dougados, M., Pélissier, C., Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus (1982) Arthritis Rheum, 25 (6), pp. 618-623
dc.descriptionMintz, G., Gutiérrez, G., Delezé, M., Rodríguez, E., Contraception with progestagens in systemic lupus erythematosus (1984) Contraception, 30 (1), pp. 29-38
dc.descriptionBuyon, J.P., Petri, M.A., Kim, M.Y., The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial (2005) Ann Intern Med, 142, pp. 953-962
dc.descriptionSánchez-Guerrero, J., González-Pérez, M., Durand-Carbajal, M., Menopause hormonal therapy in women with systemic lupus erythematosus (2007) Arthritis Rheum, 56 (9), pp. 3070-3079
dc.descriptionLahita, R.G., Hormonal contraception and replacement and the use of androgens in the antiphospholipid syndrome (2000) J Autoimmun, 15, pp. 213-216
dc.descriptionKlippel, J.H., Karsh, J., Stahl, N.I., A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus (1979) Arthritis Rheum, 22, pp. 1321-1325
dc.descriptionAbu-Shakra, M., Zalmanson, S., Neumann, L., Influenza virus vaccination of patients with systemic lupus erythematosus: Effects on disease activity (2000) J Rheumatol, 27, pp. 1681-1685
dc.descriptionO'Neill, S.G., Isenberg, D.A., Immunizing patients with systemic lupus erythematosus: A review of effectiveness and safety (2006) Lupus, 15 (11), pp. 778-783
dc.descriptionKuruma, K.A., Borba, E.F., Lopes, M.H., Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus (2007) Lupus, 16 (5), pp. 350-354
dc.descriptionLiang, M.H., Fortin, P.R., Isenberg, D.A., Snaith, L., Quantitative clinical assessment of disease activity in systemic lupus erythematosus: Progress report and research agenda (1991) Rheumatol Int, 11, pp. 133-136
dc.descriptionStrand, V., Gladman, D., Isenberg, D., Outcome measures to be used in clinical trials in systemic lupus erythematosus (1999) J Rheumatol, 26, pp. 490-497
dc.descriptionStrand, V., Gladman, D., Isenberg, D., Endpoints: Consensus recommendations from OMERACT IV (2000) Lupus, 9, pp. 322-327
dc.descriptionBombardier, C., Gladman, D.D., Urowitz, M.B., Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE (1992) Arthritis Rheum, 35 (6), pp. 630-640
dc.descriptionGladman, D.D., Ibañez, D., Urowitz, M.B., Systemic lupus erythematosus disease activity index 2000 (2002) J Rheumatol, 29, pp. 288-291
dc.descriptionMachado, C., Ruperto, N., Consenso em Reumatologia Pediátrica Parte II - definição de melhora clínica para o lúpus critematoso sistêmico e dermatomiosite juvenil. (2005) Rev Bras Reumatol, 45 (1), pp. 14-19
dc.descriptionGladman, D., Ginzler, E., Goldsmith, C., The development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology damage index for systemic lupus erythematosus (1996) Arthritis Rheum, 39 (3), pp. 363-369
dc.descriptionGladman, D.D., Goldsmith, C.H., Urowitz, M.B., The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison (2000) J Rheumatol, 27 (2), pp. 373-376
dc.languagept
dc.publisher
dc.relationRevista Brasileira de Reumatologia
dc.rightsfechado
dc.sourceScopus
dc.titleConsensus Of Systemic Lupus Erythematosus [consenso De Lúpus Eritematoso Sistêmico]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución